Nursing homes continue to struggle to get their employees vaccinated, according to recent data. Despite their priority status, only half of nursing home workers in the U.S. had received their first shot by the beginning of March. (The New York Times)

The Food and Drug Administration approved Abecma, Bristol Myers Squibb and bluebird bio’s CAR-T therapy. List price for the drug, which treats multiple myeloma, has been set at $419,500. (Endpoints News)

The Biden administration plans to double the number of pharmacy vaccination sites across the U.S. Pharmacies have thus far administered more doses than mass vaccination sites. (POLITICO)

The U.S. is seeing a new uptick in COVID-19 cases and health officials are urging the public to maintain precautions. New cases surged 10% during the past week, while hospitalizations and deaths have similarly increased. (Reuters)

Makers of virtual mental health apps like Talkspace have seen their profiles grow substantially during the pandemic – the city of Reno even provided free app access to all its residents. But some conventional therapists argue the quality of care is questionable. (STAT)